Table 3 Comorbidities characteristics of patients infected with COVID-19

HTN

Yes

128 (12.0%)

28 (21.9%)

100 (78.1%)

 < 0.001^‡

DM

Yes

122 (11.5%)

22 (18.0%)

100 (82.0%)

 < 0.001^‡

CVD

Yes

44 (4.1%)

2 (4.5%)

42 (95.5%)

 < 0.001^‡

CKD

Yes

40 (3.8%)

15 (37.5%)

25 (62.5%)

0.020^‡

COPD

Yes

15 (1.4%)

0 (0.0%)

15 (100%)

0.115^‡

HIV

Yes

2 (0.2%)

0 (0.0%)

2 (100%)

 < 0.001^‡

HBV

Yes

5 (0.5%)

0 (0.0%)

5 (100%)

0.012^‡

Cancer

Yes

17 (1.6%)

3 (17.6%)

14 (82.4%)

0.002^‡

Respiratory

Yes

30 (2.8%)

2 (6.7%)

28 (93.3%)

 < 0.001^‡

GI

Yes

49 (4.6%)

46 (93.9%)

3 (6.1%)

 < 0.001^‡

Neurology

Yes

7 (0.7%)

7 (100%)

0 (0.0%)

0.017^‡

Endocrine

Yes

18 (1.7%)

8 (44.4%)

10 (55.6%)

0.345^‡

Liver

Yes

30 (2.8%)

8 (26.7%)

22 (73.3%)

0.001^‡

Hematology

Yes

4 (0.4%)

0 (0.0%)

4 (100%)

0.026^‡

Dermatology

Yes

34 (3.2%)

12 (35.3%)

22 (64.7%)

0.016^‡

Psychology

Yes

5 (0.5%)

1 (20.0%)

4 (80.0%)

0.110^‡

Other diseases

Yes

33 (3.1%)

19 (57.6%)

14 (42.4%)

0.799^‡